| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.46 | 0.003 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |